Results 181 to 190 of about 383,213 (283)

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

B-EPIC: A Transformer-Based Language Model for Decoding B Cell Immunodominance Patterns. [PDF]

Adv Sci (Weinh)
Liang JZ, Wang Y, Sun C, Liu T, Wu Z, Chen L, Chen L, Li P, Li Z, Zhang C, Lu B, Chen Y, Gu B, Zhong Q, Wang XW, Zeng MS, Liu J.   +16 more
europepmc   +1 more source

Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases

Rare Metals, EarlyView.
ABSTRACT Chronic inflammatory skin diseases, encompassing immune‐inflammatory conditions and infection‐associated dermatoses, pose significant clinical challenges due to high prevalence, recurrence, and therapeutic resistance, affect over 30% of the global population.
Zehao Lan, Shengjie Xue, Junyi Yin, Shaolei Wang, Yunlei Zhou, Jieyue Liao   +5 more
wiley   +1 more source

Twenty-year Patient-reported Outcomes After Surgery, Radiotherapy, or Brachytherapy for Localized Prostate Cancer. [PDF]

Eur Urol Open Sci
Zamora V, Garin O, Suárez JF, Guedea F, Pont À, Pardo Y, Goñi A, Mariño A, Hervás A, Herruzo I, Cabrera P, Sancho G, Ponce de León J, Macías V, Gutiérrez C, Castells M, Ferrer M, Multicenter Spanish Group for Clinically Localized Prostate Cancer.   +17 more
europepmc   +1 more source

Who gets redeployed? Inventor characteristics and resource redeployment decisions

Strategic Management Journal, EarlyView.
Abstract Research Summary While the literature highlights the benefits of internally redeploying resources, there is less empirical guidance on which resources are most likely to be redeployed. We examine the relationship between inventor characteristics and redeployment decisions, motivated by the tension between costs and benefits of keeping a ...
Kyungsoo Kim, Isin Guler, Samina Karim
wiley   +1 more source

Mortality attributable to modifiable lifestyle factors in the Spanish cohort of the European prospective investigation into cancer and nutrition (EPIC) study. [PDF]

BMC Public Health
Cirera L, Huerta JM, Moreno-Iribas C, Jiménez A, Mokoroa O, Guevara M, Andueza N, Sánchez MJ, Petrova D, Luján-Barroso L, Salmerón D, Chirlaque MD.   +11 more
europepmc   +1 more source

Platform competition and strategic trade‐offs for complementors: Heterogeneous reactions to the entry of a new platform

Strategic Management Journal, EarlyView.
Abstract Research Summary We study how the entry of a rival platform affects the strategies of the incumbent's complementors. The latter face a trade‐off: While the entry threatens their benefits from indirect network effects, it also allows them to escape intense within‐platform competition.
Johannes Loh, Ambre Elsas‐Nicolle
wiley   +1 more source

A Comparative Analysis of the Functional Outcomes Between Retzius-Sparing and Conventional Robot-Assisted Radical Prostatectomy Using the Expanded Prostate Cancer Index Composite. [PDF]

Cancers (Basel)
Shimura S, Koguchi D, Tabata KI, Shiba I, Shiono Y, Mori K, Hirano S, Ikeda M, Tsumura H, Ishii D, Matsumoto K.   +10 more
europepmc   +1 more source

Liquid Phase TEM of Diffusing Emulsion Droplets

Small, EarlyView.
Motion of emulsion droplets was observed via in situ liquid phase transmission electron microscopy. Analysis revealed that the motion is self‐affine and influenced by multiple stochastic processes, as well as a fractal landscape created by the electron beam.
Maria A. Vratsanos, Evangelos Bakalis, Chiwoo Park, Francesco Zerbetto, Nathan C. Gianneschi   +4 more
wiley   +1 more source